COMMUNIQUÉS West-GlobeNewswire

Flexion Therapeutics to Present at Needham & Company's 17th Annual Healthcare Conference

19/03/2018 - 14:00

BURLINGTON, Mass., March 19, 2018 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq: FLXN ) today announced that Michael Clayman, M.D., President and Chief Executive Officer, and Dan Deardorf, Senior Vice President [...]

Wildflower Acquires Retail and Cultivation Licenses in LA

19/03/2018 - 14:00

VANCOUVER, British Columbia, March 19, 2018 (GLOBE NEWSWIRE) -- Wildflower Marijuana Inc. (CSE:SUN) (FWB:RSP) (“Wildflower” or the "Company") signs agreement to acquire multiple California marijuana licenses in the City [...]

SELLAS Life Sciences’ Phase 2 Results for Galinpepimut-S in High-Risk Multiple Myeloma Presented at European Society for Blood and Marrow Transplantation Meeting

19/03/2018 - 13:45

- Galinpepimut-S (GPS) induced immune activation against Wilms tumor-1 (WT1) antigen as well as multifunctional cross-epitope T-cell reactivity in patients with aggressive multiple myeloma - Correlation noted between [...]

OncoMed Announces Appointment of John Lewicki, PhD, as President, Chief Executive Officer and a member of the Board of Directors

19/03/2018 - 13:32

REDWOOD CITY, Calif., March 19, 2018 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals, Inc. (NASDAQ: OMED ), a clinical-stage biopharmaceutical company focused on discovering and developing novel anti-cancer therapeutics, [...]

United Health Products Forms Medical Advisory Board

19/03/2018 - 13:30

HENDERSON, Nev., March 19, 2018 (GLOBE NEWSWIRE) -- United Health Products, Inc. (UHP) (OTC:UEEC), manufacturer and marketer of HemoStyp®, a patented hemostatic gauze for the healthcare and wound care sectors, is [...]

Progenics Pharmaceuticals Announces Presentation of AZEDRA® (iobenguane I 131) Biochemical Tumor Marker Data at the 2018 Endocrine Society (ENDO) Annual Meeting

19/03/2018 - 13:30

NEW YORK, March 19, 2018 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX ), an oncology company developing innovative medicines and other products for targeting and treating cancer, announced that [...]

Eyenovia Announces Conference Call and Webcast for Fourth Quarter and Full Year 2017 Financial Results

19/03/2018 - 13:30

NEW YORK, March 19, 2018 (GLOBE NEWSWIRE) -- Eyenovia Inc. (“Eyenovia”) (NASDAQ: EYEN ), a clinical stage biopharmaceutical company developing a pipeline of ophthalmology products utilizing its patented piezo-print [...]

Histogenics Corporation to Present at Needham & Company’s 17th Annual Healthcare Conference

19/03/2018 - 13:30

WALTHAM, Mass., March 19, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq: HSGX ), a leader in the development of restorative cell therapies that may offer rapid-onset pain relief and restored [...]

American Gene Technologies Gains Additional Immuno-Oncology Patent

19/03/2018 - 13:30

ROCKVILLE, Md., March 19, 2018 (GLOBE NEWSWIRE) -- American Gene Technologies International Inc. (AGT), a leading gene and cell therapy company, today announced receipt of a second immuno-oncology patent on the [...]

Cellectar Biosciences Granted Orphan Drug Designation for CLR 131 to Treat Neuroblastoma

19/03/2018 - 13:05

MADISON, Wis., March 19, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences (Nasdaq: CLRB ), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment [...]

Sorrento Therapeutics Welcomes Jiong Shao as Chief Financial Officer and Reaffirms Intent to Seek Nasdaq/HKSE Dual Listing in 2018

19/03/2018 - 13:00

SAN DIEGO, March 19, 2018 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE ) ("Sorrento") announced today that it appointed Mr Jiong Shao as Executive Vice President and Chief Financial Officer. Jiong is an [...]

Corium to Present at the 17th Annual Needham Healthcare Conference

19/03/2018 - 13:00

MENLO PARK, Calif., March 19, 2018 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq: CORI ), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty [...]

Collegium Announces the Appointment of Shirley Kuhlmann as General Counsel

19/03/2018 - 13:00

CANTON, Mass., March 19, 2018 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL ) today announced the appointment of Shirley Kuhlmann to the newly created position of Executive Vice President and General [...]

resTORbio Announces Formation of Clinical Advisory Board

19/03/2018 - 13:00

Esteemed Experts Engaged as Company Advances Clinical Development Program Phase 2b Data for Lead Program Expected in the Second Half of 2018 BOSTON, March 19, 2018 (GLOBE NEWSWIRE) -- resTORbio, Inc. (NASDAQ: TORC ) [...]

MannKind Announces Participation at the H.C. Wainwright Annual Global Life Sciences Conference

19/03/2018 - 13:00

WESTLAKE VILLAGE, Calif., March 19, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD ) focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as [...]

Catalyst Biosciences to Present at The Needham and Company 17th Annual Healthcare Conference

19/03/2018 - 13:00

SOUTH SAN FRANCISCO, Calif., March 19, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO ), a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology [...]

Fibrocell Reports 2017 Financial Results and Recent Highlights

19/03/2018 - 13:00

- Company to Host Conference Call and Webcast Today at 8:30 a.m. EDT - EXTON, Pa., March 19, 2018 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ: FCSC ), a gene therapy company focused on transformational [...]

Cellectar Biosciences to Host 2017 Financial Results and Business Update Conference Call on March 22, 2018

19/03/2018 - 13:00

MADISON, Wis., March 19, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences (Nasdaq: CLRB ), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment [...]

Mersana Strengthens Board of Directors Leadership with Appointment of Willard H. Dere, M.D., Professor at the University of Utah and Retired Chief Medical Officer of Amgen

19/03/2018 - 13:00

CAMBRIDGE, Mass., March 19, 2018 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN ), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates ( [...]